Industry: Medical Devices & Consumables
Published Date: 2024-12-12
Pages: 131 Pages
Report ld: 3400201
Request Sample
Customized Report
Prostate Fusion Biopsy Market Size(US$)

CAGR 2024-2030
5.5%
Market Size,2030
USD 721
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
Valued at US$ 523 million in 2024, the global Prostate Fusion Biopsy market is forecast to reach US$ 721 million by 2030, at a CAGR of 5.5% during the forecast period.
A Prostate Fusion Biopsy is a medical procedure used to obtain tissue samples from the prostate gland to diagnose prostate cancer. It combines two imaging techniques—transrectal ultrasound (TRUS) and magnetic resonance imaging (MRI)—to guide the biopsy. This fusion of imaging helps doctors precisely target areas of the prostate that may be suspicious for cancer, especially in cases where previous biopsies were inconclusive or in patients with elevated prostate-specific antigen (PSA) levels but no obvious abnormalities on ultrasound.
The US & Canada market for Prostate Fusion Biopsy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The China market for Prostate Fusion Biopsy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The Europe market for Prostate Fusion Biopsy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key manufacturers of Prostate Fusion Biopsy include Philips, GE Healthcare, KOELIS, FUJIFILM, Eigen Health, Canon, Esaote SPA, Shenzhen Mindray Bio-Medical Electronics, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Prostate Fusion Biopsy, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Prostate Fusion Biopsy, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Prostate Fusion Biopsy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Prostate Fusion Biopsy sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Prostate Fusion Biopsy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Prostate Fusion Biopsy sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Philips, GE Healthcare, KOELIS, FUJIFILM, Eigen Health, Canon, Esaote SPA, Shenzhen Mindray Bio-Medical Electronics, etc.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Prostate Fusion Biopsy in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Prostate Fusion Biopsy manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prostate Fusion Biopsy sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Prostate Fusion Biopsy Product Introduction
1.2 Market by Type
1.2.1 Global Prostate Fusion Biopsy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Equipment
1.2.3 Consumables
1.3 Market by Application
1.3.1 Global Prostate Fusion Biopsy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Laboratory
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Prostate Fusion Biopsy Revenue Estimates and Forecasts 2019-2030
2.2 Global Prostate Fusion Biopsy Revenue by Region
2.2.1 Global Prostate Fusion Biopsy Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Prostate Fusion Biopsy Revenue by Region (2019-2024)
2.2.3 Global Prostate Fusion Biopsy Revenue by Region (2025-2030)
2.2.4 Global Prostate Fusion Biopsy Revenue Market Share by Region (2019-2030)
2.3 Global Prostate Fusion Biopsy Sales Estimates and Forecasts 2019-2030
2.4 Global Prostate Fusion Biopsy Sales by Region
2.4.1 Global Prostate Fusion Biopsy Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Prostate Fusion Biopsy Sales by Region (2019-2024)
2.4.3 Global Prostate Fusion Biopsy Sales by Region (2025-2030)
2.4.4 Global Prostate Fusion Biopsy Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Prostate Fusion Biopsy Sales by Manufacturers
3.1.1 Global Prostate Fusion Biopsy Sales by Manufacturers (2019-2024)
3.1.2 Global Prostate Fusion Biopsy Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Prostate Fusion Biopsy in 2023
3.2 Global Prostate Fusion Biopsy Revenue by Manufacturers
3.2.1 Global Prostate Fusion Biopsy Revenue by Manufacturers (2019-2024)
3.2.2 Global Prostate Fusion Biopsy Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Prostate Fusion Biopsy Revenue in 2023
3.3 Global Key Players of Prostate Fusion Biopsy, Industry Ranking, 2021 VS 2022
3.4 Global Prostate Fusion Biopsy Sales Price by Manufacturers (2019-2024)
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Prostate Fusion Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Prostate Fusion Biopsy, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Prostate Fusion Biopsy, Product Offered and Application
3.8 Global Key Manufacturers of Prostate Fusion Biopsy, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Prostate Fusion Biopsy Sales by Type
4.1.1 Global Prostate Fusion Biopsy Historical Sales by Type (2019-2024)
4.1.2 Global Prostate Fusion Biopsy Forecasted Sales by Type (2025-2030)
4.1.3 Global Prostate Fusion Biopsy Sales Market Share by Type (2019-2030)
4.2 Global Prostate Fusion Biopsy Revenue by Type
4.2.1 Global Prostate Fusion Biopsy Historical Revenue by Type (2019-2024)
4.2.2 Global Prostate Fusion Biopsy Forecasted Revenue by Type (2025-2030)
4.2.3 Global Prostate Fusion Biopsy Revenue Market Share by Type (2019-2030)
4.3 Global Prostate Fusion Biopsy Price by Type
4.3.1 Global Prostate Fusion Biopsy Price by Type (2019-2024)
4.3.2 Global Prostate Fusion Biopsy Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Prostate Fusion Biopsy Sales by Application
5.1.1 Global Prostate Fusion Biopsy Historical Sales by Application (2019-2024)
5.1.2 Global Prostate Fusion Biopsy Forecasted Sales by Application (2025-2030)
5.1.3 Global Prostate Fusion Biopsy Sales Market Share by Application (2019-2030)
5.2 Global Prostate Fusion Biopsy Revenue by Application
5.2.1 Global Prostate Fusion Biopsy Historical Revenue by Application (2019-2024)
5.2.2 Global Prostate Fusion Biopsy Forecasted Revenue by Application (2025-2030)
5.2.3 Global Prostate Fusion Biopsy Revenue Market Share by Application (2019-2030)
5.3 Global Prostate Fusion Biopsy Price by Application
5.3.1 Global Prostate Fusion Biopsy Price by Application (2019-2024)
5.3.2 Global Prostate Fusion Biopsy Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Prostate Fusion Biopsy Market Size by Type
6.1.1 US & Canada Prostate Fusion Biopsy Sales by Type (2019-2030)
6.1.2 US & Canada Prostate Fusion Biopsy Revenue by Type (2019-2030)
6.2 US & Canada Prostate Fusion Biopsy Market Size by Application
6.2.1 US & Canada Prostate Fusion Biopsy Sales by Application (2019-2030)
6.2.2 US & Canada Prostate Fusion Biopsy Revenue by Application (2019-2030)
6.3 US & Canada Prostate Fusion Biopsy Market Size by Country
6.3.1 US & Canada Prostate Fusion Biopsy Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Prostate Fusion Biopsy Revenue by Country (2019-2030)
6.3.3 US & Canada Prostate Fusion Biopsy Sales by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Prostate Fusion Biopsy Market Size by Type
7.1.1 Europe Prostate Fusion Biopsy Sales by Type (2019-2030)
7.1.2 Europe Prostate Fusion Biopsy Revenue by Type (2019-2030)
7.2 Europe Prostate Fusion Biopsy Market Size by Application
7.2.1 Europe Prostate Fusion Biopsy Sales by Application (2019-2030)
7.2.2 Europe Prostate Fusion Biopsy Revenue by Application (2019-2030)
7.3 Europe Prostate Fusion Biopsy Market Size by Country
7.3.1 Europe Prostate Fusion Biopsy Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Prostate Fusion Biopsy Revenue by Country (2019-2030)
7.3.3 Europe Prostate Fusion Biopsy Sales by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Prostate Fusion Biopsy Market Size by Type
8.1.1 China Prostate Fusion Biopsy Sales by Type (2019-2030)
8.1.2 China Prostate Fusion Biopsy Revenue by Type (2019-2030)
8.2 China Prostate Fusion Biopsy Market Size by Application
8.2.1 China Prostate Fusion Biopsy Sales by Application (2019-2030)
8.2.2 China Prostate Fusion Biopsy Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Prostate Fusion Biopsy Market Size by Type
9.1.1 Asia Prostate Fusion Biopsy Sales by Type (2019-2030)
9.1.2 Asia Prostate Fusion Biopsy Revenue by Type (2019-2030)
9.2 Asia Prostate Fusion Biopsy Market Size by Application
9.2.1 Asia Prostate Fusion Biopsy Sales by Application (2019-2030)
9.2.2 Asia Prostate Fusion Biopsy Revenue by Application (2019-2030)
9.3 Asia Prostate Fusion Biopsy Market Size by Region
9.3.1 Asia Prostate Fusion Biopsy Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Prostate Fusion Biopsy Revenue by Region (2019-2030)
9.3.3 Asia Prostate Fusion Biopsy Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
9.3.9 Australia
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Prostate Fusion Biopsy Market Size by Type
10.1.1 Middle East, Africa and Latin America Prostate Fusion Biopsy Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Prostate Fusion Biopsy Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Prostate Fusion Biopsy Market Size by Application
10.2.1 Middle East, Africa and Latin America Prostate Fusion Biopsy Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Prostate Fusion Biopsy Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Prostate Fusion Biopsy Market Size by Country
10.3.1 Middle East, Africa and Latin America Prostate Fusion Biopsy Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Prostate Fusion Biopsy Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Prostate Fusion Biopsy Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Corporate Profile
11.1 Philips
11.1.1 Philips Company Information
11.1.2 Philips Overview
11.1.3 Philips Prostate Fusion Biopsy Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Philips Prostate Fusion Biopsy Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Philips Recent Developments
11.2 GE Healthcare
11.2.1 GE Healthcare Company Information
11.2.2 GE Healthcare Overview
11.2.3 GE Healthcare Prostate Fusion Biopsy Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 GE Healthcare Prostate Fusion Biopsy Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GE Healthcare Recent Developments
11.3 KOELIS
11.3.1 KOELIS Company Information
11.3.2 KOELIS Overview
11.3.3 KOELIS Prostate Fusion Biopsy Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 KOELIS Prostate Fusion Biopsy Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 KOELIS Recent Developments
11.4 FUJIFILM
11.4.1 FUJIFILM Company Information
11.4.2 FUJIFILM Overview
11.4.3 FUJIFILM Prostate Fusion Biopsy Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 FUJIFILM Prostate Fusion Biopsy Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 FUJIFILM Recent Developments
11.5 Eigen Health
11.5.1 Eigen Health Company Information
11.5.2 Eigen Health Overview
11.5.3 Eigen Health Prostate Fusion Biopsy Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Eigen Health Prostate Fusion Biopsy Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Eigen Health Recent Developments
11.6 Canon
11.6.1 Canon Company Information
11.6.2 Canon Overview
11.6.3 Canon Prostate Fusion Biopsy Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Canon Prostate Fusion Biopsy Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Canon Recent Developments
11.7 Esaote SPA
11.7.1 Esaote SPA Company Information
11.7.2 Esaote SPA Overview
11.7.3 Esaote SPA Prostate Fusion Biopsy Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Esaote SPA Prostate Fusion Biopsy Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Esaote SPA Recent Developments
11.8 Shenzhen Mindray Bio-Medical Electronics
11.8.1 Shenzhen Mindray Bio-Medical Electronics Company Information
11.8.2 Shenzhen Mindray Bio-Medical Electronics Overview
11.8.3 Shenzhen Mindray Bio-Medical Electronics Prostate Fusion Biopsy Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Shenzhen Mindray Bio-Medical Electronics Prostate Fusion Biopsy Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Shenzhen Mindray Bio-Medical Electronics Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Prostate Fusion Biopsy Industry Chain Analysis
12.2 Prostate Fusion Biopsy Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Prostate Fusion Biopsy Production Mode & Process
12.4 Prostate Fusion Biopsy Sales and Marketing
12.4.1 Prostate Fusion Biopsy Sales Channels
12.4.2 Prostate Fusion Biopsy Distributors
12.5 Prostate Fusion Biopsy Customers
13 Prostate Fusion Biopsy Market Dynamics
13.1 Prostate Fusion Biopsy Industry Trends
13.2 Prostate Fusion Biopsy Market Drivers
13.3 Prostate Fusion Biopsy Market Challenges
13.4 Prostate Fusion Biopsy Market Restraints
14 Key Findings in the Global Prostate Fusion Biopsy Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Prostate Fusion Biopsy market is projected to grow from US$ 549 million in 2025 to US$ 794 million by 2032, at a CAGR of 5.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-24
Pages: 136
USD 4900.00
(Single User License)
The global Prostate Fusion Biopsy market size was US$ 549 million in 2025 and is forecast to reach a readjusted size of US$ 794 million by 2032 with a CAGR of 5.5% during the forecast period 2026-2032.
Published Date: 2026-03-24
Pages: 76
USD 4250.00
(Single User License)
The global market for Prostate Fusion Biopsy was estimated to be worth US$ 549 million in 2025 and is projected to reach US$ 794 million, growing at a CAGR of 5.5% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 102
USD 3950.00
(Single User License)
The global Prostate Fusion Biopsy market was valued at US$ 549 million in 2025 and is anticipated to reach US$ 794 million by 2032, at a CAGR of 5.5% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 116
USD 2900.00
(Single User License)
The global Prostate Fusion Biopsy market size was US$ 523 million in 2024 and is forecast to a readjusted size of US$ 756 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 78
USD 4250.00
(Single User License)
The global Prostate Fusion Biopsy market is projected to grow from US$ 523 million in 2024 to US$ 756 million by 2031, at a CAGR of 5.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 144
USD 4900.00
(Single User License)
The global market for Prostate Fusion Biopsy was estimated to be worth US$ 523 million in 2024 and is forecast to a readjusted size of US$ 756 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 99
USD 3950.00
(Single User License)
The global market for Prostate Fusion Biopsy was valued at US$ 523 million in the year 2024 and is projected to reach a revised size of US$ 756 million by 2031, growing at a CAGR of 5.5% during the forecast period.
Published Date: 2025-03-10
Pages: 85
USD 2900.00
(Single User License)
The global market for Prostate Fusion Biopsy was estimated to be worth US$ 461 million in 2023 and is forecast to a readjusted size of US$ 721 million by 2030 with a CAGR of 5.5% during the forecast period 2024-2030.
Published Date: 2024-12-12
Pages: 94
USD 3950.00
(Single User License)
The global market for Prostate Fusion Biopsy was valued at US$ 461 million in the year 2023 and is projected to reach a revised size of US$ 721 million by 2030, growing at a CAGR of 5.5% during the forecast period.
Published Date: 2024-12-12
Pages: 81
USD 2900.00
(Single User License)
The global Prostate Fusion Biopsy market is projected to grow from US$ 549 million in 2025 to US$ 794 million by 2032, at a CAGR of 5.5% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-24
Pages: 136
The global Prostate Fusion Biopsy market size was US$ 549 million in 2025 and is forecast to reach a readjusted size of US$ 794 million by 2032 with a CAGR of 5.5% during the forecast period 2026-2032.
Published: 2026-03-24
Pages: 76
The global market for Prostate Fusion Biopsy was estimated to be worth US$ 549 million in 2025 and is projected to reach US$ 794 million, growing at a CAGR of 5.5% from 2026 to 2032.
Published: 2026-01-19
Pages: 102
The global Prostate Fusion Biopsy market was valued at US$ 549 million in 2025 and is anticipated to reach US$ 794 million by 2032, at a CAGR of 5.5% from 2026 to 2032.
Published: 2026-01-08
Pages: 116
The global Prostate Fusion Biopsy market size was US$ 523 million in 2024 and is forecast to a readjusted size of US$ 756 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 78
The global Prostate Fusion Biopsy market is projected to grow from US$ 523 million in 2024 to US$ 756 million by 2031, at a CAGR of 5.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 144
The global market for Prostate Fusion Biopsy was estimated to be worth US$ 523 million in 2024 and is forecast to a readjusted size of US$ 756 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 99
The global market for Prostate Fusion Biopsy was valued at US$ 523 million in the year 2024 and is projected to reach a revised size of US$ 756 million by 2031, growing at a CAGR of 5.5% during the forecast period.
Published: 2025-03-10
Pages: 85
The global market for Prostate Fusion Biopsy was estimated to be worth US$ 461 million in 2023 and is forecast to a readjusted size of US$ 721 million by 2030 with a CAGR of 5.5% during the forecast period 2024-2030.
Published: 2024-12-12
Pages: 94
The global market for Prostate Fusion Biopsy was valued at US$ 461 million in the year 2023 and is projected to reach a revised size of US$ 721 million by 2030, growing at a CAGR of 5.5% during the forecast period.
Published: 2024-12-12
Pages: 81
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now